CARGO Therapeutics, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CRGX and buy or sell other stocks, ETFs, and their options commission-free!

About CRGX

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. 

CEO
Kevin Tang
CEOKevin Tang
Employees
167
Employees167
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2019
Founded2019
Employees
167
Employees167

CRGX Key Statistics

Market cap
216.19M
Market cap216.19M
Price-Earnings ratio
-0.96
Price-Earnings ratio-0.96
Dividend yield
Dividend yield
Average volume
1.25M
Average volume1.25M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$25.25
52 Week high$25.25
52 Week low
$3.00
52 Week low$3.00

People also own

Based on the portfolios of people who own CRGX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.